We represented the Board of Directors of Healthways, Inc. in a derivative case in the Chancery Court for Delaware defending allegations that the directors breached their fiduciary duty by approving a stock bonus as part of the CEO’s compensation. After utilizing Delaware’s new ratification statute to reaffirm the stock bonus, the case was dismissed.
Healthways (NASDAQ: HWAY) is the largest independent global provider of well-being improvement solutions. Healthways customers include employers, integrated health systems, hospitals, physicians, health plans, communities and government entities.